PPARG and fibrosis: Interestingly, arachidonic acid metabolic products have also been reported to be PPARγ ligands and transcriptional activators (Xu et al., 1999; Choi and Bothwell 2012) that inhibit the activation of inflammatory signals, thereby modulating hepatic fibrosis via PPARγ regulation (Figure 2).